GRAND RAPIDS, Michigan, July 24, 2020—Imperial Clinical Research Services has earned certification to the latest internationally-recognized ISO quality management standard.
Today, Imperial’s translation services team received an updated certification with zero findings by an ISO registrar. The new certificate is valid through August 2023.
“ISO quality management principles are directly in sync with Imperial’s commitment to excellence,” said Imperial president Steve Swanson. “These principles form the foundation of our quality management system. They contribute greatly to the class-leading quality of the global clinical trials translation management services we provide to pharmaceutical companies and CROs.”
Imperial’s ability to maintain this certificate is a key reason many pharmaceutical companies and CROs rely on Imperial for translation services to support global clinical trials.
Erica Manning leads Imperial’s translation services department. “Every member of the team works diligently to do the right thing for the right reasons,” she said. “I could not be prouder, listening in during audit interviews and hearing each person’s dedication to compliance. Our dedication is inspired by our clients, who know they will receive consistent quality from us.”
ISO upgrades its certification standards on an ongoing basis, and Imperial translation services has held an Intertek certificate since 2011.
ISO is an independent, non-governmental international organization based in Switzerland. Its alliance of experts work together to develop quality standards for products and businesses worldwide. Registrars then audit and confirm companies meet these published standards.